Business Standard

India to miss July-end Covid vaccination target as Bharat Biotech lags

The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August.

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Reuters
India will miss a target to administer over a half billion COVID-19 vaccine doses by the end of the month as Bharat Biotech - maker of its only approved homegrown shot - struggles to boost output, an analysis of government data showed on Monday.

India has undertaken one of the world's largest vaccination drives and has so far distributed some 430 million doses - more than any country except China, but less than many countries relative to its population.

The government said in May it would make 516 million shots available by the end of July. It wants to inoculate all its

Disclaimer: No Business Standard Journalist was involved in creation of this content

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in